César López-Camacho

César López-Camacho

Senior Postdoctoral Scientist

Jenner Institute, University of Oxford, UK

Email: Cesar.lopez-camacho@ndm.ox.ac.uk






Network Associate


Research Keywords: 

Vaccine Development, Arbovirus, Malaria, T. cruzi, Leishmaniasis



Cesar Lopez-Camacho holds a PhD in Molecular Biology from the University of Manchester, UK. He has postdoctoral experience in molecular biology and fidelity of gene expression in hematopoietic lineages  from UMASS Med School/UVM College of Medicine, USA.  He is currently a Postdoctoral Researcher in Vaccine Development at the Jenner Institute.  
As a researcher in vaccinology at the Jenner Institute, located at the University of Oxford, his main role is to identify potential emerging arboviruses and to develop vaccines for Zika, Dengue, Chikungunya and Mayaro, which two of these have now progressed to Phase I clinical trials.
In parallel, he contributes to foster and establish collaborative networks across the UK and worldwide and I have constructed novel vaccines not only limited to arboviruses but for Chagas, Malaria, and HPV vaccines.  
His experience comprises the use of DNA-based, non-replicative viralvectored vaccines (Adenovirus and MVA), VLP and subunit vaccines. 


Related Websites: 



Profile page at The Jenner Institute


Key Publications:

López-Camacho C, Abbink P, Larocca RA, Dejnirattisai W, Boyd M, BadamchiZadeh A, Wallace ZR, Doig J, Velazquez RS, Neto RDL, Coelho DF, Kim YC, Donald CL, Owsianka A, De Lorenzo G, Kohl A, Gilbert SC, Dorrell L,

Mongkolsapaya J, Patel AH, Screaton GR, Barouch DH, Hill AVS, Reyes-Sandoval A. Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors. Nat Commun. 2018 Jun 22;9(1):2441. doi: 10.1038/s41467-018-04859-5. PubMed PMID: 29934593; PubMed Central PMCID: PMC6015009.

Cesar Lopez-Camacho, Stuart Dowall, Victoria Graham, Stephen FindlayWilson, Emma Rayner, Young Chan Kim, Roger Hewson,  Arturo Reyes-Sandoval A. Zika vaccine based on chimpanzee adenovirus ChAdOx1 elicits lineagetranscending sterile immunity and prevents colonisation of brain and ovaries. Preprint: https://doi.org/10.1101/514877

Tatsis N, Fitzgerald JC, Reyes-Sandoval A, Harris-McCoy KC, Hensley SE, Zhou  D, Lin SW, Bian A, Xiang ZQ, Iparraguirre A, Lopez-Camacho C, Wherry EJ, Ertl HC. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood. 2007 Sep 15;110(6):1916-23. Epub 2007 May 17. PubMed PMID: 17510320; PubMed Central PMCID: PMC1976365.